A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology

Tumors develop within complex cell-to-cell interactions, with accessory cells playing a relevant role starting in the early phases of cancer progression. This event occurs in a three-dimensional (3D) environment, which to date, has been difficult to reproduce in vitro due to its complexity. While bi-dimensional cultures have generated substantial data, there is a progressive awareness that 3D culture strategies may rapidly increase the understanding of tumor development and be used in anti-cancer compound screening and for predicting response to new drugs utilizing personalized approaches. However, simple systems capable of rapidly rebuilding cancer tissues ex-vivo in 3D are needed and could be used for a variety of applications. Therefore, we developed a flat, handheld and versatile 3D cell culture bioreactor that can be loaded with tumor and/or normal cells in combination which can be monitored using a variety of read-outs. This biocompatible device sustained 3D growth of tumor cell lines representative of various cancers, such as pancreatic and breast adenocarcinoma, sarcoma, and glioblastoma. The cells repopulated the thin matrix which was completely separated from the outer space by two gas-permeable membranes and was monitored in real-time using both microscopy and luminometry, even after transportation. The device was tested in 3D cytotoxicity assays to investigate the anti-cancer potential of chemotherapy, biologic agents, and cell-based therapy in co-cultures. The addition of luciferase in target cancer cells is suitable for comparative studies that may also involve parallel in vivo investigations. Notably, the system was challenged using primary tumor cells harvested from lung cancer patients as an innovative predictive functional assay for cancer responsiveness to checkpoint inhibitors, such as nivolumab. This bioreactor has several novel features in the 3D-culture field of research, representing a valid tool useful for cancer investigations, drug screenings, and other toxicology approaches.

[1]  Ivan Martin,et al.  Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study , 2005, Journal of cellular physiology.

[2]  C. Ries,et al.  Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab , 2009, Oncogene.

[3]  C. Hendriksen,et al.  Reduction Strategies in Animal Research: A Review of Scientific Approaches at the Intra-experimental, Supra-experimental and Extra-experimental Levels , 2005, Alternatives to laboratory animals : ATLA.

[4]  Li-Hsin Han,et al.  Modeling Physiological Events in 2D vs. 3D Cell Culture. , 2017, Physiology.

[5]  N. Baldini,et al.  Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas , 2015, Stem cells.

[6]  G. Borchard,et al.  In vitro models for immunogenicity prediction of therapeutic proteins , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Laurent Ségalat,et al.  High‐throughput screening and small animal models, where are we? , 2010, British journal of pharmacology.

[8]  J. Kassis,et al.  3D in vitro tissue models and their potential for drug screening , 2013, Expert opinion on drug discovery.

[9]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[10]  Tobias Schmelzle,et al.  Engineering tumors with 3D scaffolds , 2007, Nature Methods.

[11]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.

[12]  Marc Bickle,et al.  Screening out irrelevant cell-based models of disease , 2016, Nature Reviews Drug Discovery.

[13]  S. Sahoo,et al.  3-D tumor model for in vitro evaluation of anticancer drugs. , 2008, Molecular pharmaceutics.

[14]  A. Knight Systematic reviews of animal experiments demonstrate poor contributions toward human healthcare. , 2008, Reviews on recent clinical trials.

[15]  Francesco Pampaloni,et al.  Three-Dimensional Cell Cultures in Toxicology , 2009, Biotechnology & genetic engineering reviews.

[16]  K. Lamperska,et al.  2D and 3D cell cultures – a comparison of different types of cancer cell cultures , 2016, Archives of medical science : AMS.

[17]  Y. Hérault,et al.  Generation and Use of Transgenic Mice in Drug Discovery , 2014 .

[18]  K. Wanner,et al.  Methods and Principles in Medicinal Chemistry , 2007 .

[19]  Kinam Park,et al.  Development of an in vitro 3D tumor model to study therapeutic efficiency of an anticancer drug. , 2013, Molecular pharmaceutics.

[20]  Brendon M. Baker,et al.  Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues , 2012, Journal of Cell Science.

[21]  Maddaly Ravi,et al.  3D Cell Culture Systems: Advantages and Applications , 2015, Journal of cellular physiology.

[22]  Chi-Ping Day,et al.  Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges , 2015, Cell.

[23]  Darren Finlay,et al.  3-Dimensional Culture Systems for Anti-Cancer Compound Profiling and High-Throughput Screening Reveal Increases in EGFR Inhibitor-Mediated Cytotoxicity Compared to Monolayer Culture Systems , 2014, PloS one.

[24]  A. Maiorana,et al.  Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer , 2019, Scientific Reports.

[25]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[26]  L. Romero,et al.  Alternative Models in Drug Discovery and Development Part II: In Vivo Nonmammalian and Exploratory/Experimental Human Models , 2014 .

[27]  L. Romero,et al.  Alternative Models in Drug Discovery and Development Part I: In Silico and In Vitro Models , 2014 .

[28]  J. Wargo,et al.  Hallmarks of response to immune checkpoint blockade , 2017, British Journal of Cancer.

[29]  W. Luyten,et al.  Three‐dimensional cell culture models for anticancer drug screening: Worth the effort? , 2018, Journal of cellular physiology.

[30]  Kathleen A Fitzgerald,et al.  Life in 3D is never flat: 3D models to optimise drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[31]  E. A. Elsayed,et al.  In Vitro and In Vivo Anti-Breast Cancer Activities of Some Synthesized Pyrazolinyl-estran-17-one Candidates , 2018, Molecules.

[32]  Georges Noel,et al.  Three-Dimensional Cell Culture: A Breakthrough in Vivo , 2015, International journal of molecular sciences.